Xebio Holdings Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2016/01/28 | ¥39.55 | ¥6.34 | -84.0% |
| 2015/11/12 | ¥18.21 | ¥11.60 | -36.3% |
| 2015/07/30 | ¥114.34 | ¥56.44 | -50.6% |
| 2015/05/07 | ¥-28.98 | ¥-21.47 | +25.9% |
Shareholder Composition
Updated 2026/08/01Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥18 | -50.0% |
| 2025 | ¥35 | +16.7% |
| 2024 | ¥30 | 0.0% |
| 2023 | ¥30 | 0.0% |
| 2022 | ¥30 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥239,293M | ¥242,433M | ¥250,603M | ¥252,331M |
| Gross Profit | ¥91,773M | ¥92,887M | ¥97,671M | ¥95,094M |
| Operating Income | ¥8,327M | ¥4,205M | ¥7,006M | ¥2,371M |
| Pretax Income | ¥8,900M | ¥4,625M | ¥3,182M | -¥2,213M |
| Net Income | ¥5,397M | ¥2,592M | ¥971M | -¥2,164M |
| EPS | ¥121.58 | ¥58.31 | ¥22.46 | -¥52.27 |
| Operating Margin | 3.48% | 1.73% | 2.80% | 0.94% |
| Balance Sheet | ||||
| Total Assets | ¥211,300M | ¥209,530M | ¥203,959M | ¥205,996M |
| Total Equity | ¥122,364M | ¥124,450M | ¥121,718M | ¥118,157M |
| Total Liabilities | ¥88,936M | ¥85,080M | ¥82,241M | ¥87,839M |
| Cash | ¥32,890M | ¥24,941M | ¥19,855M | ¥15,808M |
| Interest-bearing Debt | ¥12,634M | ¥9,953M | ¥7,366M | ¥6,286M |
| Equity Ratio | 57.91% | 59.39% | 59.68% | 57.36% |
| D/E Ratio | 0.10 | 0.08 | 0.06 | 0.05 |
| Cash Flow | ||||
| Operating CF | ¥7,020M | ¥4,274M | ¥12,057M | ¥9,681M |
| Investing CF | -¥5,477M | -¥8,041M | -¥9,578M | -¥11,263M |
| Financing CF | -¥7,911M | -¥4,138M | -¥7,531M | -¥3,323M |
| Free CF | ¥1,378M | -¥2,859M | ¥3,139M | -¥127M |
| Efficiency | ||||
| ROE | 4.41% | 2.08% | 0.80% | -1.83% |
| ROA | 2.55% | 1.24% | 0.48% | -1.05% |
Latest IR Information
-
Notice Regarding Grant of Stock-Based Compensation for Directors
Resolved to issue and grant 187 stock-based compensation options to two directors (foreign directors excluded), comprising 18,700 shares of common stock as the target shares, with 100 shares per option. Grant date: 2026/09/15; exercise period: 2026/09/16 to 2056/09/15. Exercise price...
Read more -
Fiscal Year Ending March 2027 Q1 Financial Summary (Japan GAAP) (Consolidated)
Consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 68,2420 hundred million yen (YoY +6.1%), operating income of 3,949 hundred million yen (YoY +38.7%), ordinary income of 4,200 hundred million yen (YoY...
Read more -
[Xebio Holdings] Share Option Issuance Confirmed | June 2026
Xebio Holdings will issue 2,180 new share subscription rights on June 12, 2026, with a total of 58 recipients including directors and employees. The exercise price is 107,000 yen, and allocation to eligible recipients has been finalized.
Read more -
Stock Option Grant Decision|June 2026
Xebio Holdings will allocate 2,180 stock acquisition rights to 58 individuals on June 12, 2026, with an exercise period from June 13, 2028, to June 12, 2033. The purpose is to incentivize performance improvement and increase corporate value.
Read more
Latest News (5 items)
Company Information
About
Xebio Holdings Co., Ltd., through its subsidiaries, operates in the sporting goods business in Japan. The company engages in the sale of sporting goods and apparel. It operates integrated mega specialty stores under The Super Sports XEBIO brand; small and medium scale sporting equipment specialty stores under the XEBIO Sports Express brand; urban sporting goods specialty stores under the Victoria brand; small-scale sporting goods stores under the NEXAS brand; sporting goods specialty stores under the Takeda Sports brand; golf products specialty stores under the Victoria Golf and Golf Partner brands; outdoor specialty stores under the L-Breath brand; and specialty apparel stores under the next and X'tyle brands. The company also operates sports eyewear stores under the X'tyleVision brand; health food and fitness, and medical products stores under the Xiasis brand; Free Blades, an ice hockey club team; Xebio Arena, a sports arena; and multipurpose arena under Flat Hachinohe brand. In addition, it is involved in the marketing, research and consulting, event promotion, and property management activities; research and development operations; operation of sports related digital platforms; and e-commerce management business. Further, the company engages in the sales agency business, human resource development, and temporary staffing businesses; and credit card business. Xebio Holdings Co., Ltd. was founded in 1962 and is headquartered in Koriyama, Japan.